{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:37:26Z","timestamp":1786538246782,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100025250","name":"Vancouver Coastal Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025250","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","award":["RC-2021-00272"],"award-info":[{"award-number":["RC-2021-00272"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-026-01481-3","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T04:44:11Z","timestamp":1780807451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Participant perspectives on a safe supply program in Vancouver, Canada: impacts, satisfaction and improvement priorities"],"prefix":"10.1186","volume":"23","author":[{"given":"Zia","family":"Mawani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Clare","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Holliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"key":"1481_CR1","unstructured":"British Columbia Coroners Service. Unregulated Drug Deaths - Summary. BC Coroners Service. 2025. https:\/\/app.powerbi.com\/view?r=eyJrIjoiM2JlNDY1MTItYjBiNS00NWNiLWJlZjAtNzAzNzQ3ZTYwMzg3IiwidCI6IjZmZGI1MjAwLTNkMGQtNGE4YS1iMDM2LWQzNjg1ZTM1OWFkYyJ9"},{"issue":"7","key":"1481_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/0706743717711167","volume":"62","author":"JK Eibl","year":"2017","unstructured":"Eibl JK, Morin K, Leinonen E, Marsh DC. The state of opioid agonist therapy in Canada 20 years after federal oversight. Can J Psychiatry. 2017;62(7):444\u201350. https:\/\/doi.org\/10.1177\/0706743717711167","journal-title":"Can J Psychiatry"},{"key":"1481_CR3","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.220579","author":"G Matskiv","year":"2022","unstructured":"Matskiv G, Marshall T, Krieg O, Viste D, Ghosh SM. Virtual overdose monitoring services: a novel adjunctive harm reduction approach for addressing the overdose crisis. Can Med Assoc J. 2022. https:\/\/doi.org\/10.1503\/cmaj.220579","journal-title":"Can Med Assoc J"},{"key":"1481_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.drugpo.2019.02.005","volume":"71","author":"C Strike","year":"2019","unstructured":"Strike C, Watson TM. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada. Int J Drug Policy. 2019;71:178\u201382. https:\/\/doi.org\/10.1016\/j.drugpo.2019.02.005","journal-title":"Int J Drug Policy"},{"issue":"9","key":"1481_CR5","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/add.14664","volume":"114","author":"MA Irvine","year":"2019","unstructured":"Irvine MA, Kuo M, Buxton JA, Balshaw R, Otterstatter M, Macdougall L, Milloy MJ, Bharmal A, Henry B, Tyndall M, Coombs D, Gilbert M. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic. Addiction (Abingdon England). 2019;114(9):1602\u201313. https:\/\/doi.org\/10.1111\/add.14664","journal-title":"Addiction (Abingdon England)"},{"key":"1481_CR6","doi-asserted-by":"publisher","first-page":"104339","DOI":"10.1016\/j.drugpo.2024.104339","volume":"125","author":"S Ledlie","year":"2024","unstructured":"Ledlie S, Garg R, Cheng C, Kolla G, Antoniou T, Bouck Z, Gomes T. Prescribed safer opioid supply: a scoping review of the evidence. Int J Drug Policy. 2024;125:104339. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104339","journal-title":"Int J Drug Policy"},{"key":"1481_CR7","doi-asserted-by":"publisher","first-page":"109440","DOI":"10.1016\/j.drugalcdep.2022.109440","volume":"235","author":"TD Brothers","year":"2022","unstructured":"Brothers TD, Leaman M, Bonn M, Lewer D, Atkinson J, Fraser J, Gillis A, Gniewek M, Hawker L, Hayman H, Jorna P, Martell D, O\u2019Donnell T, Rivers-Bowerman H, Genge L. Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness. Drug Alcohol Depend. 2022;235:109440. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109440","journal-title":"Drug Alcohol Depend"},{"issue":"36","key":"1481_CR8","doi-asserted-by":"publisher","first-page":"E1233","DOI":"10.1503\/cmaj.220892","volume":"194","author":"T Gomes","year":"2022","unstructured":"Gomes T, Kolla G, McCormack D, Sereda A, Kitchen S, Antoniou T. Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario. CMAJ. 2022;194(36):E1233\u201342. https:\/\/doi.org\/10.1503\/cmaj.220892","journal-title":"CMAJ"},{"issue":"1","key":"1481_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12954-022-00614-8","volume":"19","author":"B Lew","year":"2022","unstructured":"Lew B, Bodkin C, Lennox R, O\u2019Shea T, Wiwcharuk G, Turner S. The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study. Harm Reduct J. 2022;19(1):29. https:\/\/doi.org\/10.1186\/s12954-022-00614-8","journal-title":"Harm Reduct J"},{"key":"1481_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076336","author":"A Slaunwhite","year":"2024","unstructured":"Slaunwhite A, Min JE, Palis H, Urbanoski K, Pauly B, Barker B, Crabtree A, Bach P, Krebs E, Dale L, Meilleur L, Nosyk B. Effect of risk mitigation guidance for opioid and stimulant dispensations on mortality and acute care visits during Dual Public Health Emergencies: retrospective cohort study. BMJ. 2024. https:\/\/doi.org\/10.1136\/bmj-2023-076336","journal-title":"BMJ"},{"key":"1481_CR11","unstructured":"Kolla G, Fajber K. Safer opioid supply program evaluation: a comparison of safer opioid supply client outcomes from 2022 to 2023. London: London Intercommunity Health Center. 2023. https:\/\/www.nss-aps.ca\/sites\/default\/files\/resources\/2023-LIHC-safer\/opioid\/supply-Evaluation.pdf"},{"key":"1481_CR12","unstructured":"Kolla G, Long C, Perri M, Bowra A, Penn R. Safer opioid supply program: Preliminary report. London Intercommunity Health Centre. 2021. https:\/\/lihc.on.ca\/wp-content\/uploads\/2022\/01\/2021-SOS-Evaluation-Full.pdf"},{"key":"1481_CR13","unstructured":"Atkinson K. Parkdale Queen West community health centre safer opioid supply 2023 evaluation report. 2023. https:\/\/pqwchc.org\/wp-content\/uploads\/PQWCHC_safer\/opioid\/supply_EvaluationReport-Final-2023.pdf"},{"issue":"1","key":"1481_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12954-023-00776-z","volume":"20","author":"M Haines","year":"2023","unstructured":"Haines M, O\u2019Byrne P. Safer opioid supply: qualitative program evaluation. Harm Reduct J. 2023;20(1):53. https:\/\/doi.org\/10.1186\/s12954-023-00776-z","journal-title":"Harm Reduct J"},{"key":"1481_CR15","doi-asserted-by":"publisher","first-page":"104157","DOI":"10.1016\/j.drugpo.2023.104157","volume":"120","author":"M Karamouzian","year":"2023","unstructured":"Karamouzian M, Rafat B, Kolla G, Urbanoski K, Atkinson K, Bardwell G, Bonn M, Tousenard N, Henderson N, Bowles J, Boyd J, Brunelle C, Filkowski EJ, Gomes J, Guta T, Hyska A, Ivsins E, Kennedy A, Laruence MC, Martignetti G, Nafeh L, Salters F, Tu K, Strike D, Pauly C. Werb, D. Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: a qualitative analysis. Int J Drug Policy. 2023;120:104157. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104157","journal-title":"Int J Drug Policy"},{"key":"1481_CR16","unstructured":"Office of the Provincial Health Officer. A review of prescribed safer supply programs across British Columbia: recommendations for future action. Government of British Columbia. 2023. https:\/\/www2.gov.bc.ca\/assets\/gov\/health\/about-bc-s-health-care-system\/office-of-the-provincial-health-officer\/reports-publications\/special-reports\/a-review-of-prescribed-safer-supply-programs-across-bc.pdf"},{"key":"1481_CR17","doi-asserted-by":"publisher","first-page":"108202","DOI":"10.1016\/j.drugalcdep.2020.108202","volume":"216","author":"A Ivsins","year":"2020","unstructured":"Ivsins A, Boyd J, Mayer S, Collins A, Sutherland C, Kerr T, McNeil R. Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study. Drug Alcohol Depend. 2020;216:108202. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108202","journal-title":"Drug Alcohol Depend"},{"issue":"19","key":"1481_CR18","doi-asserted-by":"publisher","first-page":"E674","DOI":"10.1503\/cmaj.211515","volume":"194","author":"S Klaire","year":"2022","unstructured":"Klaire S, Sutherland C, Kerr T, Kennedy MC. A low-barrier, flexible safe supply program to prevent deaths from overdose. CMAJ. 2022;194(19):E674\u20136. https:\/\/doi.org\/10.1503\/cmaj.211515","journal-title":"CMAJ"},{"key":"1481_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104564","author":"KA Speed","year":"2024","unstructured":"Speed KA, Choi J, Felicella G, Sedgemore KO, Mok WY, Milloy MJ, DeBeck K, Kerr T, Hayashi K. (2024). Preferred pharmaceutical-grade opioids to reduce the use of unregulated opioids: a cross-sectional analysis among people who use unregulated opioids in Vancouver, Canada. Int J Drug Policy, 132, 104564. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104564","journal-title":"Int J Drug Policy"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-026-01481-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01481-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01481-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:02:52Z","timestamp":1786536172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-026-01481-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1481"],"URL":"https:\/\/doi.org\/10.1186\/s12954-026-01481-3","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"<b>Declaration<\/b>s"}}],"article-number":"131"}}